CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
49783-84-8 | 1,5-二甲基-1h-吡唑-3-甲酰氯 | 1,5-dimethyl-1h-pyrazole-3-carbonyl chloride | | | | |
497832-98-1 | 4-溴-1-甲基-5-(三氟甲基)-1h-吡唑 | 4-bromo-1-methyl-5-(trifluoromethyl)-1h-pyrazole | | | | |
497832-99-2 | 1-甲基-3-三氟甲基-4-溴-1h-吡唑 | 4-bromo-1-methyl-3-trifluoromethyl-1h-pyrazole | | | | |
497833-03-1 | | 4-bromo-1-methyl-5-(trifluoromethyl)-1h-pyrazole-3-carboxylic acid | | | | |
497833-04-2 | 1-甲基-5-三氟甲基-1h-吡唑-4-醛 | 1-methyl-5-(trifluoromethyl)-1h-pyrazole-4-carbaldehyde | | | | |
497833-05-3 | 4-溴-2-甲基-5-三氟甲基-2h-吡唑-3-羧酸 | 4-bromo-2-methyl-5-trifluoromethyl-2 h -pyrazole-3-carboxylic acid | | | | |
497833-27-9 | | givinostat | | | | |
497836-10-9 | | d77 | | | | |
497839-62-0 | | aee788 | | | | |
49784-42-1 | | cadmate(1-), [n,n-bis(carboxymethyl)glycinato(3-)-n,o,o',o'']-, potassium, ( be | | | | |
49784-44-3 | | cadmium (2+) nta | | | | |
49784-47-6 | | barium, ((ethylenedinitrilo)tetraacetato)cobaltate(iii), tetrahydrate | | | | |
497843-22-8 | 1-苄基-5-苯基-1,2,3,6-四氢吡啶-4-甲酸乙酯 | ethyl 1-benzyl-5-phenyl-1,2,3,6-tetrahydropyridine-4-carboxylate | | | | |
49785-74-2 | | 1,2-benzisothiazolin-3-one, 2-(2-oxo-3-piperidyl)-, 1,1-dioxide | | | | |
49785-85-5 | 1-甲基-3-溴-2-哌啶酮 | 3-bromo-1-methyl-2-piperidone | | | | |
497853-95-9 | | (4-aminophenyl)(1-methyl-1h-imidazol-2-yl)methanol | | | | |
497854-55-4 | | 2-(4-fluorobenzoyl)-4-methylpyridine | | | | |
497854-88-3 | | 2-(4-fluorobenzoyl)-6-methylpyridine | | | | |
497854-91-8 | | 2-(4-fluorobenzoyl)-5-methylpyridine | | | | |
497855-87-5 | | (2-mercapto-1-propyl-1h-imidazol-5-yl)methanol | | | | |
497855-88-6 | (1-丙基-1h-咪唑-5-基)甲醇 | (1-propyl-1h-imidazol-5-yl)methanol | | | | |
49786-02-9 | | 1,3-Dimethyl-6-ethyluracil | C8H12N2O2 | 168.19 | | |
49786-32-5 | | 5h)-dione, 6,7-dihydro-1,3-dimethyl-1h-cyclopentapyrimidine-4(3h | | | | |
49786-33-6 | | 5h)-dione, 6,7-dihydro-3-cyclohexyl-1-methyl-1h-cyclopentapyrimidine-4(3h | | | | |
49786-34-7 | | 5h)-dione, 6,7-dihydro-1-methyl-3-phenyl-1h-cyclopentapyrimidine-4(3h | | | | |
49786-40-5 | | 1h-cyclopentapyrimidine-1-acetic acid, 2,3,4,5,6,7-hexahydro-2,4-dioxo-3-phenyl | | | | |
49786-42-7 | | 1h-cyclopentapyrimidine-1-acetamide, 2,3,4,5,6,7-hexahydro-3-cyclohexyl-2,4-dio | | | | |
49786-43-8 | | 2,3,4,5,6,7-hexahydro-2,4-dioxo-3-phenyl-1h-cyclopentapyrimidine-1-acetamid | | | | |
49786-46-1 | | 1h-cyclopentapyrimidine-1-acetamide, 2,3,4,5,6,7-hexahydro-2,4-dioxo-n,n,3-trim | | | | |
49786-48-3 | | 1h-cyclopentapyrimidine-1-acetamide, 2,3,4,5,6,7-hexahydro-n,n-dimethyl-2,4-dio | | | | |
49786-55-2 | | 1h-cyclopentapyrimidine-2,4(3h,5h)-dione, 6,7-dihydro-1-(2-(diethylamino)ethyl) | | | | |
49786-56-3 | | -3-phenyl- | | | | |
49786-62-1 | | 5h)-dione, 6,7-dihydro-3-allyl-1-methyl-1h-cyclopentapyrimidine-4(3h | | | | |
49786-89-2 | | 2-(4-cyanophenoxy)-propanoic aci ethyl ester | | | | |
497861-77-5 | | (R)-tert-butyl (4-oxobutan-2-yl)carbamate | | | | |
497864-07-0 | | 3-(2,4-dichloro-phenoxymethyl)-benzoic acid methyl ester | | | | |
497867-62-6 | | 2-imino-1-(2-methoxyethyl)-10-methyl-5-oxo-n-(2-phenylethyl)-1,5-dihydro-2h-dipyrido[1,2-a:2,3-d]pyrimidine-3-carboxamide | | | | |
49787-00-0 | | 4-hydroxy-benzamidine oxime | | | | |
49787-02-2 | | 4-(5-methyl-1,2,4-oxadiazol-3-yl)phenol | | | | |
497883-22-4 | (s,r,r)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a′]二萘-4-基)二(1-苯基乙基)胺 | | | | | |
4979-02-6 | | 3-methylphenyl 4-pyridinyl ether | | | | |
4979-32-2 | N,N'-二环己基-2-苯并噻唑亚磺酰胺 | N,N'-dicyclohexyl-2-Benzothiazole sulfenamide | C19H26N2S2 | 346.58 | | |
4979-46-8 | | phenol,4-methyl-2-(1,1,3,3-tetramethylbutyl)- | C15H24O | 220.35 | | |
4979-72-0 | | 2,5-diethoxy-4-(4-morpholinyl)-benzenediazoniu tetrafluoroborate(1-) | | | | |
4979-75-3 | | n,1-diethyl-2-methyl-5-benzimidazole-sulfonamide | | | | |
4979-79-7 | | 4-chloro-2-phenylquinoline | | | | |
49791-06-2 | | Chloromethyl heptyl ether | C8H17ClO | 164.67 | | |
49791-37-9 | | oxo-pyrrolidin-1-yl-acetic acid | | | | |
497915-42-1 | 1-boc-4-(5-碘-2-吡啶基)哌嗪 | 1-boc-4-(5-iodo-2-pyridyl)piperazine | | | | |
49792-23-6 | | medicagenic acid-3-o-glucopyranoside | | | | |